Cellular resilience: 5-HT neurons in Tph2(-/-) mice retain normal firing behavior despite the lack of brain 5-HT. 2015

Alberto Montalbano, and Jonas Waider, and Mario Barbieri, and Ozan Baytas, and Klaus-Peter Lesch, and Renato Corradetti, and Boris Mlinar
Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.

Considerable evidence links dysfunction of serotonin (5-hydroxytryptamine, 5-HT) transmission to neurodevelopmental and psychiatric disorders characterized by compromised "social" cognition and emotion regulation. It is well established that the brain 5-HT system is under autoregulatory control by its principal transmitter 5-HT via its effects on activity and expression of 5-HT system-related proteins. To examine whether 5-HT itself also has a crucial role in the acquisition and maintenance of characteristic rhythmic firing of 5-HT neurons, we compared their intrinsic electrophysiological properties in mice lacking brain 5-HT, i.e. tryptophan hydroxylase-2 null mice (Tph2(-/-)) and their littermates, Tph2(+/-) and Tph2(+/+), by using whole-cell patch-clamp recordings in a brainstem slice preparation and single unit recording in anesthetized animals. We report that the active properties of dorsal raphe nucleus (DRN) 5-HT neurons in vivo (firing rate magnitude and variability; the presence of spike doublets) and in vitro (firing in response to depolarizing current pulses; action potential shape) as well as the resting membrane potential remained essentially unchanged across Tph2 genotypes. However, there were subtle differences in subthreshold properties, most notably, an approximately 25% higher input conductance in Tph2(-/-) mice compared with Tph2(+/-) and Tph2(+/+) littermates (p<0.0001). This difference may at least in part be a consequence of slightly bigger size of the DRN 5-HT neurons in Tph2(-/-) mice (approximately 10%, p<0.0001). Taken together, these findings show that 5-HT neurons acquire and maintain their signature firing properties independently of the presence of their principal neurotransmitter 5-HT, displaying an unexpected functional resilience to complete brain 5-HT deficiency.

UI MeSH Term Description Entries
D008856 Microscopy, Fluorescence Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. Immunofluorescence microscopy utilizes antibodies that are labeled with fluorescent dye. Fluorescence Microscopy,Immunofluorescence Microscopy,Microscopy, Immunofluorescence,Fluorescence Microscopies,Immunofluorescence Microscopies,Microscopies, Fluorescence,Microscopies, Immunofluorescence
D000200 Action Potentials Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli. Spike Potentials,Nerve Impulses,Action Potential,Impulse, Nerve,Impulses, Nerve,Nerve Impulse,Potential, Action,Potential, Spike,Potentials, Action,Potentials, Spike,Spike Potential
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014365 Tryptophan Hydroxylase An enzyme that catalyzes the hydroxylation of TRYPTOPHAN to 5-HYDROXYTRYPTOPHAN in the presence of NADPH and molecular oxygen. It is important in the biosynthesis of SEROTONIN. Tryptophan Monooxygenase,Hydroxylase, Tryptophan,Monooxygenase, Tryptophan
D015221 Potassium Channels Cell membrane glycoproteins that are selectively permeable to potassium ions. At least eight major groups of K channels exist and they are made up of dozens of different subunits. Ion Channels, Potassium,Ion Channel, Potassium,Potassium Channel,Potassium Ion Channels,Channel, Potassium,Channel, Potassium Ion,Channels, Potassium,Channels, Potassium Ion,Potassium Ion Channel
D046509 Tissue Culture Techniques A technique for maintaining or growing TISSUE in vitro, usually by DIFFUSION, perifusion, or PERFUSION. The tissue is cultured directly after removal from the host without being dispersed for cell culture. Culture Technique, Tissue,Culture Techniques, Tissue,Tissue Culture Technique
D049452 Green Fluorescent Proteins Protein analogs and derivatives of the Aequorea victoria green fluorescent protein that emit light (FLUORESCENCE) when excited with ULTRAVIOLET RAYS. They are used in REPORTER GENES in doing GENETIC TECHNIQUES. Numerous mutants have been made to emit other colors or be sensitive to pH. Green Fluorescent Protein,Green-Fluorescent Protein,Green-Fluorescent Proteins,Fluorescent Protein, Green,Fluorescent Proteins, Green,Protein, Green Fluorescent,Protein, Green-Fluorescent,Proteins, Green Fluorescent,Proteins, Green-Fluorescent
D059326 Serotonergic Neurons Neurons whose primary neurotransmitter is SEROTONIN. Serotoninergic Neurons,Neuron, Serotonergic,Neuron, Serotoninergic,Neurons, Serotonergic,Neurons, Serotoninergic,Serotonergic Neuron,Serotoninergic Neuron
D018345 Mice, Knockout Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes. Knockout Mice,Mice, Knock-out,Mouse, Knockout,Knock-out Mice,Knockout Mouse,Mice, Knock out
D018377 Neurotransmitter Agents Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. Nerve Transmitter Substance,Neurohormone,Neurohumor,Neurotransmitter Agent,Nerve Transmitter Substances,Neurohormones,Neurohumors,Neuromodulator,Neuromodulators,Neuroregulator,Neuroregulators,Neurotransmitter,Neurotransmitters,Substances, Nerve Transmitter,Transmitter Substances, Nerve,Substance, Nerve Transmitter,Transmitter Substance, Nerve

Related Publications

Alberto Montalbano, and Jonas Waider, and Mario Barbieri, and Ozan Baytas, and Klaus-Peter Lesch, and Renato Corradetti, and Boris Mlinar
August 2008, Journal of neural transmission (Vienna, Austria : 1996),
Alberto Montalbano, and Jonas Waider, and Mario Barbieri, and Ozan Baytas, and Klaus-Peter Lesch, and Renato Corradetti, and Boris Mlinar
July 2015, Psychopharmacology,
Alberto Montalbano, and Jonas Waider, and Mario Barbieri, and Ozan Baytas, and Klaus-Peter Lesch, and Renato Corradetti, and Boris Mlinar
March 2005, Journal of neurophysiology,
Alberto Montalbano, and Jonas Waider, and Mario Barbieri, and Ozan Baytas, and Klaus-Peter Lesch, and Renato Corradetti, and Boris Mlinar
September 2002, The Journal of pharmacology and experimental therapeutics,
Alberto Montalbano, and Jonas Waider, and Mario Barbieri, and Ozan Baytas, and Klaus-Peter Lesch, and Renato Corradetti, and Boris Mlinar
June 1999, Annals of the New York Academy of Sciences,
Alberto Montalbano, and Jonas Waider, and Mario Barbieri, and Ozan Baytas, and Klaus-Peter Lesch, and Renato Corradetti, and Boris Mlinar
June 2023, Biomolecules,
Alberto Montalbano, and Jonas Waider, and Mario Barbieri, and Ozan Baytas, and Klaus-Peter Lesch, and Renato Corradetti, and Boris Mlinar
April 1980, Neuropharmacology,
Alberto Montalbano, and Jonas Waider, and Mario Barbieri, and Ozan Baytas, and Klaus-Peter Lesch, and Renato Corradetti, and Boris Mlinar
October 2014, Neuropharmacology,
Alberto Montalbano, and Jonas Waider, and Mario Barbieri, and Ozan Baytas, and Klaus-Peter Lesch, and Renato Corradetti, and Boris Mlinar
January 2004, Hippocampus,
Alberto Montalbano, and Jonas Waider, and Mario Barbieri, and Ozan Baytas, and Klaus-Peter Lesch, and Renato Corradetti, and Boris Mlinar
January 2013, Frontiers in pharmacology,
Copied contents to your clipboard!